159 related articles for article (PubMed ID: 9761676)
1. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
[TBL] [Abstract][Full Text] [Related]
2. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
Proba K; Honegger A; Plückthun A
J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
[TBL] [Abstract][Full Text] [Related]
3. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
5. Antibody scFv fragments without disulfide bonds made by molecular evolution.
Proba K; Wörn A; Honegger A; Plückthun A
J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
[TBL] [Abstract][Full Text] [Related]
6. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
7. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
Riechmann L
J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
[TBL] [Abstract][Full Text] [Related]
8. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.
Saerens D; Conrath K; Govaert J; Muyldermans S
J Mol Biol; 2008 Mar; 377(2):478-88. PubMed ID: 18262543
[TBL] [Abstract][Full Text] [Related]
9. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
[TBL] [Abstract][Full Text] [Related]
12. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
[TBL] [Abstract][Full Text] [Related]
13. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant design and expression of human three-domain antibody against BoNTa].
Wang H; Yin J; Shi J; Meng LL; Li PZ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):223-5. PubMed ID: 15989265
[TBL] [Abstract][Full Text] [Related]
15. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
16. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
Jäger M; Gehrig P; Plückthun A
J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
[TBL] [Abstract][Full Text] [Related]
17. Folding and oxidation of the antibody domain C(H)3.
Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of mouse monoclonal antibody 13-1 against a porphyrin derivative: identification of a disulfide bond in CDR-H3 of Mab 13-1.
Akashi S; Kato K; Torizawa T; Dohmae N; Yamaguchi H; Kamachi M; Harada A; Imanaka T; Shimada I; Takio K
Biochem Biophys Res Commun; 1997 Nov; 240(3):566-72. PubMed ID: 9398605
[TBL] [Abstract][Full Text] [Related]
19. Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms.
Monsellier E; Bedouelle H
J Mol Biol; 2006 Sep; 362(3):580-93. PubMed ID: 16926023
[TBL] [Abstract][Full Text] [Related]
20. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.
Honegger A; Plückthun A
J Mol Biol; 2001 Jun; 309(3):687-99. PubMed ID: 11397089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
